N/A
N=20
Radio Frequency Microneedling for Suprapatellar Skin
Skin Laxity
Bottom Line
View on ClinicalTrials.gov: NCT03507036 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcome: Primary: Photographic Knee Laxity and Texture Evaluation — 1.87; 2.02 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Profound system (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Texas Southwestern Medical Center
- Primary completion
- Jan 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Photographic Knee Laxity and Texture Evaluation |
1.87; 2.02 | — |
| PRIMARY Epidermal Thickness |
96.53333; 106.9; 98.33333; 92.36667; 91.36667 | — |
| PRIMARY Dermal Thickness |
1104.7; 1179.2; 1241.367; 1167.933; 1122.233 | — |
| PRIMARY Change in Blood Flow at 0.25mm |
0.3294; 0.23; -0.02; 0.080534; 0.1045 | — |
| PRIMARY Transepidermal Water Loss |
9.379; 9.6007; 10.9986; 11.744; 8.772 | — |
| PRIMARY Skin Elasticity |
0.80199; 0.811731094; 0.82434; 0.77234; 0.74615 | — |
| PRIMARY Change in Skin Laxity |
0.7408; 12.5364; 3.75791; 0.85623; -5.54778 | — |
| PRIMARY Histological Analysis- Collagen 1 |
1.38; 1.00; 1.04 | — |
| PRIMARY Gene Expression- Collagen 1 |
1.91; 1.38 | — |
| PRIMARY Epidermal Density |
0.00380558; 0.028518; 0.004336; 0.020107; 0.00392152 | — |
| PRIMARY Histological Analysis- Collagen 3 |
0.63; 0.72; 0.71 | — |
| PRIMARY Histological Analysis- Elastin |
1.29; 0.90; 0.58 | — |
| PRIMARY Gene Expression- Collagen 3 |
2.07; 1.36 | — |
| PRIMARY Gene Expression- Elastin |
0.89; 1.74 | — |
| PRIMARY Gene Expression- Interluekin 6 |
18.60; 4.04 | — |
Summary
The human skin aging process is characterized by thinning dermis, atrophy of the extracellular matrix, and reduced collagen synthesis. Loss of collagen in the dermis is of aesthetic concern, as it is the main structural support in the dermis and its loss results in skin laxity. Photo-damaged skin, mostly due to UVR, causes degradation of elastic fibers. This is histologically seen as disorganized tangles of elastin. Additionally, as humans age, skin tends to appear more dry due to its poor hydration and turgor capacity. The use of minimally invasive aesthetic treatments in reducing signs of aging has been gaining in popularity over surgical treatments in recent years. Several energy types including, laser, radiofrequency, infrared, and ultrasound, have been developed for facial rejuvenation. These treatments induce controlled thermal damage into the dermis and cause collagen contraction and neocollagenesis resulting in skin tightening over several months. For improving appearance of other anatomical areas, micro-focused ultrasound has been the preferred method, but has shown limited success in tightening the suprapatellar skin.
As with facial skin aging, the suprapatellar skin loses elasticity with age and begins to sag. Noninvasive treatments used for the face may also be used in other anatomical areas to produce the same effects of tightening. Minimally invasive bipolar radiofrequency produces a controlled thermal injury in a fractional manner without damaging the dermal-epidermal junction, epidermis or subcutis. Radiofrequency, unlike lasers, are chromophore-independent providing better penetration than lasers, and spare sweat glands, sebaceous glands, and hair follicles.
Eligibility Criteria
Inclusion Criteria
- Healthy male and female adults between ages 18-75 years of age.
- Subjects who can read, understand, and sign the Informed Consent Form.
- Subjects willing and able to comply with all study requirements
- Fitzpatrick skin type I-III
Exclusion Criteria
- Subjects with active localized or systemic infections.
- Immunocompromised subjects.
- Subjects with coagulation disorder.
- History of skin photosensitivity disorders, or use of photosensitizing drugs (e.g., tetracycline or sulfa drugs).
- Pregnant and/or lactating (All female volunteers will be advised about using birth control during the period of study).
- In the opinion of the trained clinician, subject is unwilling or unable to adhere to all study requirements, including application and follow-up visits.
- Subjects with a history of radiation therapy to the treatment area.
- Subject has a history of allergy to lidocaine or ester-based local anesthetics.
- Subjects with any skin pathology or condition that could interfere with evaluation or with the use of typical ancillary medical treatments or care used before, during or after treatments.
- Subjects have undergone dermatological procedures (e.g., laser or light treatments) for the treatment of wrinkles, skin resurfacing, or skin rejuvenation in the treatment area within 1 year of study participation.
Data sourced from ClinicalTrials.gov (NCT03507036). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.